Home › Chronic Myeloid Leukemia › Bridgeport
Chronic Myeloid Leukemia clinical trials in Bridgeport, CT
3 studies for Chronic Myeloid Leukemia are looking for participants at sites in and around Bridgeport (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Stony Brook University Medical Center, Stony Brook · 18 mi away
Study of Olverembatinib (HQP1351) in Patients With CML-CP
RecruitingPhase 3
- Ascentage Investigative Site #1160, Stony Brook · 18 mi away
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
- Stony Brook University Hospital, Stony Brook · 18 mi away
About Chronic Myeloid Leukemia
Chronic myeloid leukemia (CML) is a cancer of the white blood cells. It usually affects older adults. Learn about symptoms, genetics, and treatment.
More about Chronic Myeloid Leukemia on MedlinePlus
Chronic Myeloid Leukemia trials in other cities
- Houston, TX18 studies
- New York City, NY11 studies
- Seattle, WA11 studies
- Birmingham, AL6 studies
- Detroit, MI6 studies
- Philadelphia, PA6 studies
- Portland, OR6 studies
- Chicago, IL6 studies
- Baldwin Park, CA6 studies
- Columbus, OH5 studies
- Nashville, TN5 studies
- Atlanta, GA5 studies
Other studies in Bridgeport
- Breast Cancer21 studies
- Non-Small Cell Lung Cancer14 studies
- Lung Cancer13 studies
- Acute Myeloid Leukemia12 studies
- Cardiovascular Disease9 studies
- Head and Neck Squamous Cell Carcinoma8 studies
- Cancer (all types)8 studies
- Metastatic Cancer7 studies
- Heart Failure7 studies
- Brain Aneurysm6 studies
- Prostate Cancer6 studies
- Multiple Myeloma6 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.